Search for a trial | Research with human participants

1 results

Randomized, Double-blind, Placebo-controlled, Three-Period Crossover Study to Assess the Safety and Tolerability of Inhaled PA101 in Idiopathic Pulmonary Fibrosis (IPF) Patients with Chronic Cough

Approved WMORecruitment stopped

* To assess the safety and tolerability of inhaled PA101 delivered via eFlow in patients with IPF with refractory chronic cough.* To assess the efficacy potential of inhaled PA101 by measuring the changes in cough severity and the urge-to-cough as…